HCC patients suffer less from geographic differences in organ availability.

C Schuetz1, N Dong, E Smoot

  • 1Department of Surgery, Division of Transplantation, Massachusetts General Hospital, Boston, MA.

Summary

The Model for End-Stage Liver Disease (MELD) exception points for hepatocellular carcinoma (HCC) may overestimate mortality risk. HCC patients face lower waitlist mortality compared to non-HCC patients, especially with increased organ competition.